Biogen Overview
A biopharmaceutical company called Biogen Inc. (Biogen) finds, creates, and distributes pharmaceuticals and biosimilars for the treatment of various neurological and neurodegenerative illnesses. Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fumarate), Fampyra (prolonged-release fampridine tablets), and Plegridy (peginterferon beta-1a) are among the company’s marketed medications for the treatment of multiple sclerosis (MS); Spinraza (nusinersen) is […]